MedTrace Logo

Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection

NCT05414448 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1726

Last updated 2026-04-22

No results posted yet for this study

Summary

The investigators hypothesize that the combined use of CADe system (ENDOAID) and mucosal exposure device (Endocuff Vision®) would improve the adenoma detection rate when compared to CADe system alone.

Conditions

Interventions

DEVICE

ENDOCUFF

ENDOCUFF mucousal exposure device will be used during withdrawal process of the colonoscopy.

Sponsors & Collaborators

  • University Hospital Augsburg

    collaborator OTHER

  • Changi General Hospital

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-07
Primary Completion
2025-07-07
Completion
2025-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05414448 on ClinicalTrials.gov